GlassScriptPhysician profile
Timothy J Bell
NPI 1740224831
$52,874.60
in general payments reported to CMS, 2019-2025
21 companies · $3,295 in 2025
The $3,295 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,257 · 2020: $49.87 · 2021: $9,520 · 2022: $12K · 2023: $12K · 2024: $8,323 · 2025: $3,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $23K · Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $22,611.00 |
| Food and Beverage | $855.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $41,771.66 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $9,542.54 | 2019-2021 | |
| Abbvie INC. | $786.21 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $160.80 | 2021-2025 | |
| Pfizer INC. | $94.68 | 2021-2024 | |
| Hologic Sales and Service, LLC | $82.56 | 2019-2025 | Aptima, Thinprep 2000 Processor, Fluent Fluid Management System |
| Meditrina | $50.87 | 2022-2023 | |
| Millicent US INC | $49.04 | 2025 | Femlyv, Intrarosa |
| Therapeuticsmd, INC. | $46.85 | 2022 | |
| Exeltis, USA INC. | $46.16 | 2022-2023 | Slynd |
| Axonics, INC. | $37.07 | 2021-2023 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $34.72 | 2022-2023 | |
| Innovation Technologies INC | $33.09 | 2023 | Irrisept |
| Novo Nordisk INC | $29.87 | 2023 | |
| Biogen, INC. | $25.29 | 2025 | Zurzuvae |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $17.40 | 2022 | |
| Astellas Pharma US INC | $14.96 | 2022 | |
| Boston Scientific Corporation | $14.68 | 2021 | |
| Avion Pharmaceuticals | $13.33 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.79 | 2019 | |
| Covidien LP | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.